The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 11, 2015, Pages 2061-2068

  Arsov, Christian ^a   Becker, Nikolaus ^c   Rabenalt, Robert ^a   Hiester, Andreas ^a   Quentin, Michael ^a   Dietzel, Frederic ^a   Antoch, Gerald ^a   Gabbert, Helmut E ^b   Albers, Peter ^a   Schimmöller, Lars ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Department of Orthopedic Surgery   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Gleason grading; Gleason score; Image guided prostate biopsy; Magnetic resonance imaging; MR guided prostate biopsy; Prostate cancer

Indexed keywords

AGED; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; RETROSPECTIVE STUDY; CANCER GRADING; CLINICAL TRIAL; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

AGED; BIOPSY, NEEDLE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84951569707     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-1991-5     Document Type: Article

References (33)

1. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757
2. Berg KD, Toft BG, Røder MA, Brasso K, Vainer B, Iversen P (2011) Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re-evaluation. APMIS 119:239–246
3. Coard KC, Freeman VL (2004) Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies. Am J Clin Pathol 122:373–376
4. Cohen MS, Hanley RS, Kurteva T et al (2008) Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol 54:371–381
5. D’Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW (2008) Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA 299:289–295
6. Dall’Era MA, Albertsen PC, Bangma C et al (2012) Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 62:976–983
7. D’Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH (2003) Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 21:2163–2172
8. Epstein JL, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228–1242
9. Fiard G, Hohn N, Descotes JL, Rambeaud JJ, Troccaz J, Long JA (2013) Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. Urology 81:1372–1378
10. Fu Q, Moul JW, Bañez LL et al (2012) Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer. Med Oncol 29:3339–3344
11. Gilliland FD, Hoffman RM, Hamilton A et al (1999) Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol 162:1341–1345
12. Haffner J, Lemaitre L, Puech P et al (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 108(8 Pt 2):E171–E178
13. Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent- update 2013. Eur Urol 65:124–137
14. Hu Y, Ahmed HU, Carter T et al (2012) A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy. BJU Int 110:812–820
15. Jones CU, Hunt D, McGowan DG et al (2011) Radiotherapy and shortterm androgen deprivation for localized prostate cancer. N Engl J Med 365:107–118
16. Kim JY, Kim SH, Kim YH, Lee HJ, Kim MJ, Choi MS (2014) Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detection. Radiology 271:435–444
17. King CR, Long JP (2000) Prostate biopsy grading errors: a sampling problem? Int J Cancer 90:326–330
18. Le JD, Stephenson S, Brugger M et al (2014) Magnetic resonance imaging–ultrasound fusion biopsy for prediction of final prostate pathology. J Urol 192:1367–1373
19. McKenney JK, Simko J, Bonham M et al (2011) The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study. J Urol 186:465–469
20. Palisaar RJ, Graefen M, Karakiewicz PI et al (2002) Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur Urol 41:155–161
21. Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81:1142–1146
22. Porter CR, Kodama K, Gibbons RP et al (2006) 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol 176:569–574
23. Quentin M, Blondin D, Arsov C et al (2014) Prospective evaluation of MRI-guided in- bore prostate biopsy versus systematic transrectal ultrasound (TRUS)-guided prostate biopsy in biopsy-naïve men with elevated prostate-specific antigen (PSA) levels. J Urol 192:1374–1379
24. Rastinehad AR, Turkbey B, Salami SS et al (2013) Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy. J Urol 191:1749–1754
25. Schimmöller L, Quentin M, Arsov C et al (2014) MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. Eur Radiol 24:2582–2589
26. Servoll E, Saeter T, Vlatkovic L et al (2012) Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer. BJU Int 109:1489–1494
27. Sgrignoli AR, Walsh PC, Steinberg GD, Steiner MS, Epstein JI (1994) Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol 152:1077–1081
28. Siddiqui MM, Rais-Bahrami S, Truong H et al (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64:713–719
29. Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy—should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18:575–581
30. Thompson J, Lawrentschuk N, Frydenberg M, Thompson L, Stricker P (2013) The role of magnetic resonance imaging in the diagnosis and management of prostate cancer. BJU Int 112(Suppl 2):6–20
31. Turker P, Bas E, Bozkurt S et al (2013) Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival. Urol Oncol 31:93–98
32. Wysock JS, Rosenkrantz AB, Huang WC et al (2014) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 66:343–351
33. Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D’Amico AV (2005) Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 23:6992–6998